Shimazawa M - Search Results

1

Identification of VGF nerve growth factor inducible-producing cells in human spinal cords and expression change in patients with amyotrophic lateral sclerosis.

Noda Y, Tanaka M, Nakamura S, Ito J, Kakita A, Hara H, Shimazawa M. Noda Y, et al. Among authors: shimazawa m. Int J Med Sci. 2020 Feb 4;17(4):480-489. doi: 10.7150/ijms.39101. eCollection 2020. Int J Med Sci. 2020. PMID: 32174778 Free PMC article.

2

Effect of KB-2796, a new diphenylpiperazine Ca2+ antagonist, on glutamate-induced neurotoxicity in rat hippocampal primary cell cultures.

Hara H, Yokota K, Shimazawa M, Sukamoto T. Hara H, et al. Among authors: shimazawa m. Jpn J Pharmacol. 1993 Apr;61(4):361-5. doi: 10.1254/jjp.61.361. Jpn J Pharmacol. 1993. PMID: 8100595 Free article.

3

An experimental model of migraine with aura: cortical hypoperfusion following spreading depression in the awake and freely moving rat.

Shimazawa M, Hara H. Shimazawa M, et al. Clin Exp Pharmacol Physiol. 1996 Oct-Nov;23(10-11):890-2. doi: 10.1111/j.1440-1681.1996.tb01139.x. Clin Exp Pharmacol Physiol. 1996. PMID: 8911731

4

[Anti-migraine effects of lomerizine].

Hara H, Shimazawa M, Hashimoto M, Sukamoto T. Hara H, et al. Among authors: shimazawa m. Nihon Yakurigaku Zasshi. 1998 Oct;112 Suppl 1:138P-142P. doi: 10.1254/fpj.112.supplement_138. Nihon Yakurigaku Zasshi. 1998. PMID: 10190151 Japanese.

5

Alterations in neurofilament light in optic nerve in rat kainate and monkey ocular hypertension models.

Taniguchi T, Shimazawa M, Hara H. Taniguchi T, et al. Among authors: shimazawa m. Brain Res. 2004 Jul 9;1013(2):241-8. doi: 10.1016/j.brainres.2004.04.023. Brain Res. 2004. PMID: 15193534

6

Clinical potential of lomerizine, a Ca2+ channel blocker as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage.

Hara H, Toriu N, Shimazawa M. Hara H, et al. Among authors: shimazawa m. Cardiovasc Drug Rev. 2004 Fall;22(3):199-214. doi: 10.1111/j.1527-3466.2004.tb00141.x. Cardiovasc Drug Rev. 2004. PMID: 15492768 Review.

7

Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage.

Morimoto N, Shimazawa M, Yamashima T, Nagai H, Hara H. Morimoto N, et al. Among authors: shimazawa m. Brain Res. 2005 May 17;1044(1):8-15. doi: 10.1016/j.brainres.2005.02.062. Epub 2005 Apr 13. Brain Res. 2005. PMID: 15862784

8

Bunazosin, a selective alpha1-adrenoceptor antagonist, as an anti-glaucoma drug: effects on ocular circulation and retinal neuronal damage.

Hara H, Ichikawa M, Oku H, Shimazawa M, Araie M. Hara H, et al. Among authors: shimazawa m. Cardiovasc Drug Rev. 2005 Spring;23(1):43-56. doi: 10.1111/j.1527-3466.2005.tb00156.x. Cardiovasc Drug Rev. 2005. PMID: 15867947 Review.

9

Neuroprotective effects of minocycline against in vitro and in vivo retinal ganglion cell damage.

Shimazawa M, Yamashima T, Agarwal N, Hara H. Shimazawa M, et al. Brain Res. 2005 Aug 16;1053(1-2):185-94. doi: 10.1016/j.brainres.2005.06.053. Brain Res. 2005. PMID: 16051195

10

Neutrophil accumulation promotes intimal hyperplasia after photochemically induced arterial injury in mice.

Shimazawa M, Watanabe S, Kondo K, Hara H, Nakashima M, Umemura K. Shimazawa M, et al. Eur J Pharmacol. 2005 Sep 27;520(1-3):156-63. doi: 10.1016/j.ejphar.2005.07.031. Eur J Pharmacol. 2005. PMID: 16140293

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

369 results

Search Page

Filters